Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis

Fig. 4

RP11-367G18.1 and YY1 are associated with worse outcomes in patients with HNSC. (A and B) Expression levels of RP11-367G18.1 and YY1 were higher in tumor tissues than those in normal tissues in patients with HNSC from TCGA dataset. (C) Positive correlation between RP11-367G18.1 and YY1 in HNSC tissues was shown. (D) Patients with HNSC with high expression levels of RP11-367G18.1 and YY1 showed the worse overall survival. (E) Patients with HNSC with high expression levels of RP11-367G18.1, YY1, and HIF-1α showed the worse overall survival

Back to article page